Literature DB >> 2565553

Effects of L-carnitine, L-acetylcarnitine and gangliosides on the regeneration of the transected sciatic nerve in rats.

E Fernandez1, R Pallini, C Gangitano, A Del Fá, C O Sangiacomo, A Sbriccoli, J R Ricoy, G F Rossi.   

Abstract

Three pharmacological agents, L-carnitine, L-acetylcarnitine and gangliosides, were tested for their ability to enhance the regeneration of the rat sciatic nerve following transection and microsurgical repair. The drugs were administered intraperitoneally at the dose of 50 mg/kg/d for 28 and 56 d postoperatively. At the end of treatment, the motor function recovery of the peroneal component of the sciatic nerve was assessed and the regenerated nerves were analysed morphometrically on histological semi-thin sections. Also, the reinnervated extensor digitorum longus (EDL) muscles were studied histochemically using the adenosine-triphosphatase (ATP-ase) technique 56 d after surgery. Motor function assessment at 56 d after nerve repair revealed that L-acetylcarnitine-treated animals recovered a clinical grade significantly higher (p less than 0.05) than the control animals. Twenty-eight days after nerve repair, the number of myelinated fibres was significantly higher (p less than 0.05) in L-acetylcarnitine and ganglioside-treated animals than in control animals. However, 56 d after nerve repair the number of regenerated fibres in all the drug-treated groups was not significantly different from that of the control group. The EDL muscles of the drug-treated animals did not show significant differences from those of control animals with respect to fibre composition and fibre diameter although the L-acetylcarnitine-treated animals exhibited a significantly lower (p less than 0.05) degree of muscle atrophy than did the control animals. The results of the present work seem to indicate that L-acetylcarnitine and to a lesser extent gangliosides exert some favourable effect on the regeneration of the transected sciatic nerve in rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565553     DOI: 10.1080/01616412.1989.11739863

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  9 in total

Review 1.  Acetyl-L-carnitine in HIV-associated antiretroviral toxic neuropathy.

Authors:  Mike Youle
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.

Authors:  Sarah J L Flatters; Wen-Hua Xiao; Gary J Bennett
Journal:  Neurosci Lett       Date:  2006-01-06       Impact factor: 3.046

Review 3.  Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain.

Authors:  Thierry Bordet; Rebecca M Pruss
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

4.  L-Acetylcarnitine causes analgesia in mice modeling Fabry disease by up-regulating type-2 metabotropic glutamate receptors.

Authors:  Francesco Formaggio; Roberto Rimondini; Cecilia Delprete; Leonardo Scalia; Emilio Merlo Pich; Rocco Liguori; Ferdinando Nicoletti; Marco Caprini
Journal:  Mol Pain       Date:  2022 Jan-Dec       Impact factor: 3.395

5.  Pharmacokinetics of acetyl-L-carnitine given in single or multiple doses to HIV-1 Infected patients with toxic peripheral polyneuropathy.

Authors:  C Herzmann; S J Whiting; M Thomas; P Byrne; M A Johnson; M Youle
Journal:  Open AIDS J       Date:  2008-06-04

6.  Acetyl-l-carnitine and oxfenicine on cardiac pumping mechanics in streptozotocin-induced diabetes in male Wistar rats.

Authors:  Chih-Hsien Wang; Shoei-Shen Wang; Wen-Je Ko; Yih-Sharng Chen; Chun-Yi Chang; Ru-Wen Chang; Kuo-Chu Chang
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

7.  L-carnitine alleviates sciatic nerve crush injury in rats: functional and electron microscopy assessments.

Authors:  Ummü Zeynep Avsar; Umit Avsar; Ali Aydin; Muhammed Yayla; Berna Ozturkkaragoz; Harun Un; Murat Saritemur; Tolga Mercantepe
Journal:  Neural Regen Res       Date:  2014-05-15       Impact factor: 5.135

Review 8.  Recent Findings on the Effects of Pharmacological Agents on the Nerve Regeneration after Peripheral Nerve Injury.

Authors:  Samira Bolandghamat; Morteza Behnam-Rassouli
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 9.  Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?

Authors:  Katarzyna Szklener; Sebastian Szklener; Adam Michalski; Klaudia Żak; Weronika Kuryło; Konrad Rejdak; Sławomir Mańdziuk
Journal:  Nutrients       Date:  2022-01-31       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.